These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 329600)

  • 41. [Actions of carbocromen of toxic effects of digitalis (author's transl)].
    Scholtholt VJ; Fiedler V; Göbel H; Nitz RE; Pötzsch E
    Arzneimittelforschung; 1976; 26(5):876-81. PubMed ID: 989361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Paradoxical effect of carbocromen in angina pectoris].
    Montemurro G; Testoni F
    Boll Soc Ital Cardiol; 1974; 19(1):55-9. PubMed ID: 4469785
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of gum guggulu on fibrinolysis and platelet adhesiveness in coronary heart disease.
    Bordia A; Chuttani SK
    Indian J Med Res; 1979 Dec; 70():992-6. PubMed ID: 396237
    [No Abstract]   [Full Text] [Related]  

  • 44. [Role of noninvasive methods in the clinical assessment of drug action in coronary disease].
    Chlebus H
    Pol Tyg Lek; 1977 Jan; 32(5):202-6. PubMed ID: 401992
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effectiveness of using prolonged-action nitrates in ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1981 Sep; (9):24-7. PubMed ID: 6795823
    [No Abstract]   [Full Text] [Related]  

  • 46. Antiarrhythmic properties of carbocromen. Effects on depressed activity of sinoatrial and atrioventricular node.
    Sirbulescu R; Scholtholt J
    Arzneimittelforschung; 1979; 29(3):469-73. PubMed ID: 582730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intensain treatment of patients with ischemic heart disease].
    Kuzko NV
    Vrach Delo; 1972 Apr; 4():40-3. PubMed ID: 5048948
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of the effectiveness of Nitro-Mac retard forte in ischemic heart disease].
    Zamotaev IP; Venediktova MG; Lozinskiĭ LG; Mktrchian VR
    Sov Med; 1989; (12):44-6. PubMed ID: 2517154
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical experimentation with Cardiocap in subjects with coronary disease with coronary insufficiency].
    Marignani A; Martelli A; Piana G
    Minerva Cardioangiol; 1973 Sep; 21(9):629-35. PubMed ID: 4745005
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of coronary vasodilation on the healthy and ischemic myocardium in the dog].
    Tato F; Garnier M; Berdeaux A; Giudicelli JF
    Arch Farmacol Toxicol; 1978 Dec; 4(3):319-30. PubMed ID: 218502
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of metoprolol duriles in chronic coronary insufficiency].
    del Nero E; Yasbek Júnior P; Kedor H; Kiss MA; Juliano Y; Moffa PJ
    Arq Bras Cardiol; 1985 Sep; 45(3):211-6. PubMed ID: 3915200
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of antibradykinin preparations and nicotinic acid on the microcirculation and blood oxygen balance of ischemic heart disease patients in the initial stage of heart failure].
    Denisiuk VI
    Kardiologiia; 1983 Aug; 23(8):103-5. PubMed ID: 6620828
    [No Abstract]   [Full Text] [Related]  

  • 53. [Contribution to coronary therapy].
    Kappen P
    Z Allgemeinmed; 1969 Jan; 45(2):75-8. PubMed ID: 5802029
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of carbocromen on the respiratory function of rat heart mitochondria].
    Ostrowski J
    Arzneimittelforschung; 1979; 29(6):889-94. PubMed ID: 582779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Value of Iso Mack Retard in the treatment of coronary disease].
    Zminkowska U; Markiewicz M
    Wiad Lek; 1984 Apr; 37(7):496-500. PubMed ID: 6385487
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical trial of a delayed-action Trinitrine in the prevention of angina pectoris].
    Warembourg H; Niquet G; Carre A; Ginestet A
    Lille Med; 1973 Apr; 18(4):483-6. PubMed ID: 4201870
    [No Abstract]   [Full Text] [Related]  

  • 57. [Combined intenkordin and corhormone treatment of ischemic heart disease].
    Glukhen'kiĭ TT; Kuz'ko NV
    Vrach Delo; 1974 May; 5(0):55-7. PubMed ID: 4407764
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of a stable form of coronary disease with Adalat retard].
    Kraska T; Korewicki J; Niemczyk M; Opolski G; Jakubowska-Najnigier M; Słomka K; Zieliński T
    Pol Tyg Lek; 1986 Mar; 41(9):277-9. PubMed ID: 3520520
    [No Abstract]   [Full Text] [Related]  

  • 59. [A new anti-stenocardiac agent: carbochromen].
    Arcidiacono R; Sanna GP; Fornasero L
    Minerva Cardioangiol; 1971 Dec; 19(12):719-28. PubMed ID: 5129038
    [No Abstract]   [Full Text] [Related]  

  • 60. [Regulation of lipid and carbohydrate metabolism of the heart by carbocromen (author's transl)].
    Schraven E
    Arzneimittelforschung; 1976 Feb; 26(2):197-200. PubMed ID: 947199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.